CEO of Biohaven Pharmaceutical Holding Co Ltd (BHVN, Financial) Vlad Coric bought 5,000 shares of BHVN on 06/26/2019 at an average price of $40.22 a share. The total cost of this purchase was $201,100.
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders. Biohaven Pharmaceutical Holding Co Ltd has a market cap of $2.16 billion; its shares were traded at around $42.02 .
CEO Recent Trades:
- CEO Vlad Coric bought 5,000 shares of BHVN stock on 06/26/2019 at the average price of $40.22. The price of the stock has increased by 4.48% since.
Directors and Officers Recent Trades:
- Director John W Childs bought 10,000 shares of BHVN stock on 06/26/2019 at the average price of $40.37. The price of the stock has increased by 4.09% since.
For the complete insider trading history of BHVN, click here
.
